Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in Nras-Driven Hematopoietic Transformation

by Xu, Jin, Haigis, Kevin M., Firestone, Ari J., McNerney, Megan E., Li, Qing, Davis, Elizabeth, Chen, Shann-Ching, Nakitandwe, Joy, Downing, James, Le Beau, Michelle M., Shannon, Kevin, Jacks, Tyler E
Published 2015

Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis

by Yang, Ming, Govern, Christopher C., Chakraborty, Arup K., Hartzell, Catherine, Ksionda, Olga, Lemmens, Ed, Coakley, Kristen, Dail, Monique, Harvey, Richard C., Bakker, Jeroen, Lenstra, Tineke L., Ammon, Kristin, Boeter, Anne, Winter, Stuart S., Loh, Mignon, Shannon, Kevin, Wabl, Matthias, Roose, Jeroen P.
Published 2014

The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia

by Bassil, Christopher F, Ben-Sahra, Issam, Benajiba, Lina, Alexe, Gabriela, Pikman, Yana, Conway, Amy S, Burgess, Michael R, Li, Qing, Luciano, Frédéric, Auberger, Patrick, Galinsky, Ilene, DeAngelo, Daniel J, Stone, Richard M, Zhang, Yi, Perkins, Archibald S, Shannon, Kevin, Puissant, Alexandre, Stegmaier, Kimberly, Fenouille, Nina, Ramos, Azucena, Hemann, Michael
Published 2018